SOST and breast cancer: Osteolytic cancer cells, such as breast cancer cells, overexpress Sclerostin (SOST) or Dickkopf1 (Dkk1), which play inhibiting roles in the Wnt signaling pathway, leading to downregulation of cell proliferation and differentiation.